NeuroOne Medical Technologies Corporation Stock
Equities
NMTC
US64130M2098
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 USD | -4.31% | -2.63% | -29.75% |
Financials (USD)
Sales 2022 | 2.12 | Sales 2023 | 3.41 | Capitalization | 21.3M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -11M | EV / Sales 2022 | 7,761,717 x |
Net cash position 2022 | 10.94M | Net cash position 2023 | 5.14M | EV / Sales 2023 | 4,742,168 x |
P/E ratio 2022 |
-2.7
x | P/E ratio 2023 |
-1.36
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.8% |
Latest transcript on NeuroOne Medical Technologies Corporation
1 day | -4.31% | ||
1 week | -2.63% | ||
Current month | -7.50% | ||
1 month | -12.60% | ||
3 months | -11.90% | ||
6 months | +11.35% | ||
Current year | -29.75% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 09-08-19 |
David Rosa
CEO | Chief Executive Officer | 59 | 17-07-19 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 17-08-03 |
Director/Board Member | 63 | 17-08-03 | |
Edward Andrle
BRD | Director/Board Member | 66 | 20-02-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.11 | -4.31% | 38,571 |
24-04-24 | 1.16 | +1.75% | 525,154 |
24-04-23 | 1.14 | 0.00% | 52,236 |
24-04-22 | 1.14 | -0.87% | 72,192 |
24-04-19 | 1.15 | +0.88% | 19,393 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-29.75% | 30.08M | |
-15.34% | 19.18B | |
-46.15% | 2.73B | |
+14.09% | 1.84B | |
-3.39% | 1.61B | |
+23.19% | 1.18B | |
-10.58% | 1B | |
-21.72% | 898M | |
-12.15% | 710M | |
-17.56% | 694M |
- Stock Market
- Equities
- NMTC Stock